多色流式细胞术与细胞因子分析提升肾移植活检信息
该研究开发了一种将部分肾活检样本处理为单细胞进行多色流式细胞术并定量活检内细胞因子的技术。在移植肾活检中,CD8+/CD4+淋巴细胞比值≥1.2与排斥反应相关,即使显微镜下尚未明显;IL-6、IL-8、IL-10升高提示损伤更重。该技术可评估微血管内皮抗体结合及补体激活,并发现肾内白细胞亚群与外周血显著不同。
要点
- 移植肾活检CD8+/CD4+比值≥1.2与排斥反应相关。
- IL-6、IL-8、IL-10升高及CD45白细胞增多提示损伤更重。
- 流式可检测内皮抗体结合与补体激活,辅助排斥分型。
核心结论
- 流式细胞术评估白细胞亚群、微血管内皮特性及细胞因子可增强对发病机制的理解、指示疾病活动并识别治疗靶点。
研究设计与样本
- 技术开发与概念验证研究,使用移植肾活检样本,将部分样本处理为单细胞进行多色流式细胞术并定量活检内细胞因子。
主要发现
- 移植同种异体移植物中CD8+/CD4+淋巴细胞比值≥1.2与排斥反应相关,甚至早于显微镜下可见。
- CD45白细胞数量升高及IL-6、IL-8、IL-10水平升高提示更严重的损伤。
- 可检测抗体与肾微血管内皮细胞结合,并与抗体介导的排斥反应形式相对应。
- 依库珠单抗与内皮细胞结合提示补体激活,可能独立于结合抗体。
- 肾内白细胞亚群及激活状态与同一供者活检时外周血存在显著差异。
关键数值与推荐
- CD8+/CD4+淋巴细胞比值≥1.2与移植肾排斥反应相关。
- CD45白细胞升高及IL-6、IL-8、IL-10升高提示更严重损伤。
临床怎么用
- 在移植肾活检中可补充流式细胞术检测白细胞亚群、内皮抗体结合及细胞因子,以辅助评估排斥风险与损伤程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Current processing of renal biopsy samples provides limited information about immune mechanisms causing kidney injury and disease activity. We used flow cytometry with transplanted kidney biopsy samples to provide more information on the immune status of the kidney. METHODS: To enhance the information available from a biopsy, we developed a technique for reducing a fraction of a renal biopsy sample to single cells for multicolor flow cytometry and quantitation of secreted cytokines present within the biopsy sample. As proof of concept, we used our technique with transplant kidney biopsy samples to provide examples of clinically relevant immune information obtainable with cytometry. RESULTS: A ratio of CD8+ to CD4+ lymphocytes greater than or equal to 1.2 in transplanted allografts is associated with rejection, even before it is apparent by microscopy. Elevated numbers of CD45 leukocytes and higher levels of interleukin (IL)-6, IL-8, and IL-10 indicate more severe injury. Antibody binding to renal microvascular endothelial cells can be measured and corresponds to antibody-mediated forms of allograft rejection. Eculizumab binding to endothelial cells suggests complement activation, which may be independent of bound antibody. We compared intrarenal leukocyte subsets and activation states to those of peripheral blood from the same donor at the time of biopsy and found significant differences; thus the need for new techniques to evaluate immune responses within the kidney. CONCLUSION: Assessment of leukocyte subsets, renal microvascular endothelial properties, and measurement of cytokines within a renal biopsy by flow cytometry enhance understanding of pathogenesis, indicate disease activity, and identify potential targets for therapy.
引用
- Muczynski KA, Leca N, Anderson AE, et al. Multicolor Flow Cytometry and Cytokine Analysis Provides Enhanced Information on Kidney Transplant Biopsies. Kidney Int Rep. 2018. PMID: 29989006. doi:10.1016/j.ekir.2018.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。